Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B RTS

0.380
0.000
Volume:- -
Turnover:- -
Market Cap:234.84M
PE:-1.32
High:0.380
Open:0.380
Low:0.380
Close:0.380
52wk High:1.750
52wk Low:0.250
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.287
ROE:--
ROA:--
PB:--
PE(LYR):-1.32
PS:4.12

Loading ...

Company Profile

Company Name:
IMMUNOTECH-B RTS
Exchange:
SEHK
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Immunotech Biopharm Ltd is an investment holding company primarily engaged in research and development, manufacturing and commercialisation of immune cell products for treatments of cancers. The Company’s non-genetically modified cell product pipeline includes EAL and 6B11-OCIK Injection. The Company’s chimeric antigen receptor T (CAR-T) cell product pipeline includes CAR-T-19 Injection, Denocabtagene Ciloleucel Injection and aT19 Injection. The Company’s T cell receptor engineered T cell therapy (TCR-T) cell product pipeline includes YT003, YT008 and YT007. The Company mainly conducts its business in the domestic market.